Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Germ Cell Tumors
Regimen:
TIP (cisplatin + ifosfamide + paclitaxel)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Testicular Cancer - Nonseminoma…Post Chemotherapy Management…Preferred Regimens…TIP=Paclitaxel/Ifosamide/Cisplatin)…
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Second-line Chemotherapy Regimens for Metastatic Germ Cell tumors…Conventional-Dose Chemotherapy Regimens…TIP…Paclitaxel…Ifosamide...Cisplatin…
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login